Original Research
Published on 11 Mar 2022
Aging With Multiple Sclerosis: Age-Related Factors and Socioeconomic Risks
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.818652
- 3,806 views
- 8 citations
Type at least 3 characters
1,081 articles
Articles
Original Research
Published on 11 Mar 2022
Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.819911
- 2,214 views
- 6 citations
Mini Review
Published on 10 Mar 2022
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.829331
- 21,895 views
- 34 citations
Original Research
Published on 07 Mar 2022
Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.814734
- 2,263 views
- 4 citations
Original Research
Published on 07 Mar 2022
Recurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Cohort Study in Central China
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.832634
- 4,944 views
- 8 citations
Editorial
Published on 02 Mar 2022
Editorial: Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.844155
- 1,813 views
- 5 citations
Original Research
Published on 02 Mar 2022
Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.689975
- 2,887 views
- 7 citations
Case Report
Published on 01 Mar 2022
MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.845755
- 12,843 views
- 29 citations
Review
Published on 28 Feb 2022
Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.828616
- 4,359 views
- 9 citations
Review
Published on 25 Feb 2022
Preventing Multiple Sclerosis: The Pediatric Perspective
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.802380
- 5,015 views
- 7 citations
Review
Published on 25 Feb 2022
Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2021.811518
- 10,562 views
- 31 citations
Original Research
Published on 24 Feb 2022
A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.796882
- 8,215 views
- 11 citations
Original Research
Published on 24 Feb 2022
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.820256
- 2,512 views
- 10 citations
Mini Review
Published on 24 Feb 2022
A Quantitative Synthesis of Eight Decades of Global Multiple Sclerosis Research Using Bibliometrics
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.845539
- 6,001 views
- 20 citations
Original Research
Published on 23 Feb 2022
Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.843081
- 1,570 views
- 1 citation
Hypothesis and Theory
Published on 22 Feb 2022
Prevention of MS Requires Intervention on the Causes of the Disease: Reconciling Genes, Epigenetics, and Epstein Barr Virus
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.817677
- 5,579 views
- 2 citations